Sackey, Ebenezer

Primary examiner statistics: 0 patents; average approval time: 0 days
Assistant examiner statistics: 896 patents; average approval time: 897 days

Patents as Assistant Examiner

«First «Previous1 2 3 4 5 6 7 8 9 10 11 Next»Last»

Number	Title	Issue Date
8076110	Methods for producing alkyl esters This invention relates to a method for producing an alkyl ester via a transesterification or esterification reaction. The method includes (1) mixing an oil source containing a triglyceride or a carboxylic acid and a first primary alcohol or a first secondary alcohol...	12/13/2011
8076338	Kinase modulators and methods of use The present invention relates to compounds of the Formula (I) and (II) wherein R, R21, R25-R33, m, n, X21-X23, and Q1 are defined herein. The compounds modulate protein kinase enzymatic activity to mo...	12/13/2011
8034955	Therapeutic compounds and methods of use Compounds and methods useful for chemopreventative treatment of diseases such as cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, and multiple sclerosis. ...	10/11/2011
8017612	Piperazine compound and use thereof as a HCV polymerase inhibitor The present invention relates to a compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof and an anti-HC...	09/13/2011
8017615	Low hygroscopic aripiprazole drug substance and processes for the preparation thereof The present invention provides low hygroscopic forms of aripiprazole and processes for the preparation thereof which will not convert to a hydrate or lose their original solubility even when a medicinal preparation containing the anhydrous aripiprazole crystals is s...	09/13/2011
7989455	Compounds, compositions and methods Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure. ...	08/02/2011
7981897	Crystal form of (3-cyano-1H-Indo1-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone, hydrochloride The present invention relates to a hitherto unknown crystal form B of (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)-piperazin-1-yl]methanone, hydrochloride, to a process for the preparation thereof, and to the use thereof for the preparation of a medicament. ...	07/19/2011
7977482	Dark coloured azo dyes The present invention relates to a) a non-oxidative coloring agent for keratin fibers, in particular human hair, comprising at least one dye according to formula (I) or (II), b) an oxidative coloring agent for keratin fibers, in particular ...	07/12/2011
7977338	Phenylacetamides being FLT3 inhibitors Compounds of formula wherein the residues R1, R2, R3, R9, R10 and Q and X, Y and Z are as defined in the specification, salts thereof; their use, methods of their use, processes for their production, pharmaceutical composit...	07/12/2011
7973037	Cathepsin cysteine protease inhibitors This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, s...	07/05/2011
7964604	Bifeprunox mesylate maintenance dose compositions and methods for using the same The present disclosure provides novel pharmaceutical dosage forms such as a maintenance treatment dose and methods for making the same, and methods for using said compounds and maintenance treatment doses to treat and prevent diseases and/or disorders. ...	06/21/2011
7964601	Melanocortin receptor-specific compounds A melanocortin receptor-specific compound of the general formula of structure I: where X, R1, R2a, R2b, R3, R4a, R4b, R5a and R5b are a...	06/21/2011
7964583	Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents The present disclosure relates to salts and compositions of isophosphoramide mustard and isophosphoramide mustard analogs. In one embodiment the salts can be represented by the formula wherein A+ represents an am...	06/21/2011
7956088	Synthetic lactone formulations and methods of use Natural and synthetic compounds having a lactone structure methods for using and making the compounds have been disclosed. The compounds are useful as anti-bacterial, anti-fungal and anti-inflammatory agents, and for treating proliferation disorders such as melanoma...	06/07/2011
7951796	9-amino-acridine derivatives and their use for eliminating misfolded proteins The invention relates to compounds according to general formula (1) and/or their enantiomers, diastereomers as well as their pharmaceutically compatible salts, and to the use thereof for producing a medicament suited for treating diseases associated with misfolded p...	05/31/2011
7943622	Piperazines, pharmaceutical compositions and methods of use thereof Disclosed are novel piperazine derivatives that act as agonists of the α7 nAChR. Also disclosed are pharmaceutical compositions, methods of treating inflammatory conditions, methods of treating CNS disorders, methods for inhibiting cytokine release from mammalian c...	05/17/2011
7939535	Benzo[D]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors The present invention provides compounds of the general formula (I), having affinity and selectivity for the dopamine D3 receptors, their manufacture, pharmaceutical compositions containing them and their use for the therapeutic and/or prophylactic treatment of cogn...	05/10/2011
7935850	Process for hydroformylation of propylene Increasing the propylene content of the propylene feed delivered to a continuous hydroformylation process from the 95 mole % maximum level that is usual in typical chemical grade propylene to at least 97 mole %, for example to the 97.5% level obtainable from the con...	05/03/2011
7935836	Compounds comprising a linear series of five fused carbon rings, and preparation thereof The present application discloses methods for the production of organic compounds comprising a linear series of five fused carbon rings. Such compounds are useful in the production of electronic components, devices and materials. For example the methods disclosed pe...	05/03/2011
7932388	Isotopically enriched N-substituted piperazines and methods for the preparation thereof In some embodiments, this invention pertains to isotopically enriched N-substituted piperazines. In some embodiments, this invention pertains to methods for the preparation of isotopically enriched N-substituted piperazines. ...	04/26/2011
7923558	Method for obtaining pure tetrahydrocannabinol The invention relates to a method for obtaining pure tetrahydrocannabinol from reaction mixtures containing tetrahydrocannabinol compounds or from raw products containing tetrahydrocannabinol compounds. According to said method, the tetrahydrocannabinol compounds in...	04/12/2011
7910587	Quinoxalinyl dipeptide hepatitis C virus inhibitors The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS...	03/22/2011
7910766	Preparation of at least one partial oxidation and/or ammoxidation product of a hydrocarbon A process for preparing at least one partial oxidation and/or ammoxidation product of a hydrocarbon by partially dehydrogenating at least one saturated hydrocarbon H under heterogeneous catalysis and using the resulting product gas mixture A, which comprises the par...	03/22/2011
7910589	Low hygroscopic aripiprazole drug substance and processes for the preparation thereof The present invention provides low hygroscopic forms of aripiprazole and processes for the preparation thereof which will not convert to a hydrate or lose their original solubility even when a medicinal preparation containing the anhydrous aripiprazole crystals is s...	03/22/2011
7897596	Allosteric modulators of the Aadenosine receptor The present invention provides compounds of formula (I) wherein R1, R2, R3, R4 and Q have a meaning as defined herein in the specification. The compounds of formula (I) are allost...	03/01/2011
7893109	N,N-dihalogenated amino acids and derivatives The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes meth...	02/22/2011
7887784	1-[(2′-substituted)-piperazin-1′ -yl]-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents Racemic mixtures and enantiomerically pure forms of novel 1-[(2′-substituted)-piperazin-1′-yl]-isoquinolines are norepinephrine (NE) transporter (NET) inhibitor compounds. Compounds of the invention are considered therapeutic agents for central nervous system (C...	02/15/2011
7883714	Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use The invention describes novel nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated NSAID, and, optionally, at least one compound that donates, transfers or re...	02/08/2011
7884205	Salts of aripiprazole The present invention relates to acid addition salts of aripiprazole, a process for preparing said acid addition salts and their use to prepare or purify aripiprazole in the form of a free base or in the form of a pharmaceutically acceptable salt. ...	02/08/2011
7879861	Combi-molecules having EGFR and DNA targeting properties A series of new chemical agents that demonstrate anti-tumor activity are described. The new chemical agents combine two major mechanisms of anti-tumor action. In an embodiment, the agents are capable of both inhibiting EGFR and damaging DNA while also, upon degradat...	02/01/2011
7880029	Use of polyalkenyl succinimides in acrylic acid production A method for dispersing polymerization by-products and maintaining said by-products in suspension in a hydrocarbon processing system during acrylic acid and acrylate monomer formation is disclosed, which includes adding to the monomer an effective inhibiting amount ...	02/01/2011
7875605	N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them N-arylsulfonyl-3-substituted indole compounds, derivatives, analogs, tautomeric forms, stereoisomers, geometric forms, N-oxides, polymorphs and pharmaceutically acceptable salts. ...	01/25/2011
7875740	Iron-containing material suitable for use as hydrogenation catalyst The iron-containing catalyst suitable for use as a catalyst contains a) iron or a mixture containing iron and an iron-based compound. The iron has an average crystallite size ranging from 1-35 nm measured by X-ray diffraction. ...	01/25/2011
7872132	Intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole An improved process for the preparation of aripiprazole (1) which comprises (i) reacting 6-hydroxy-l-indanone (11) with 1,4-dihalobutane (12) in the presence of a base and a solvent at a temperature in the range of 90 to 110 deg C to form the novel intermediate 6-(4...	01/18/2011
7872002	Therapeutic pyrazoloquinoline derivatives The invention provides a novel chemical series of formula I, as well as methods of use thereof for binding to the benzodiazepine site of the GABAA receptor and modulating GABAA, and use of the compound of formula I for the treatment of GABA	01/18/2011
7863266	Therapeutic pyrazoloquinoline urea derivatives The invention provides a novel chemical series of formula I, as well as methods of use thereof for binding to the benzodiazepine site of the GABAA receptor and modulating GABAA, and use of the compound of formula I for the treatment of GABA	01/04/2011
7863276	Salts of modulators of PPAR and methods of treating metabolic disorders Salt forms of potent modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed. ...	01/04/2011
7863327	Therapeutic compounds and methods of use Compounds and methods useful for chemopreventative treatment of diseases such as cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, and multiple sclerosis. ...	01/04/2011
7858614	Therapeutic pyrazolonaphthyridine derivatives The invention provides a novel chemical series of formula I, as well as methods of use thereof for binding to the benzodiazepine site of the GABAA receptor and negatively modulating the α5 subtype of GABAA, and use of the compound of formula I...	12/28/2010
7855209	Allosteric modulators of the Aadenosine receptor The present invention provides compounds of formula (I) wherein R1, R2, R3, R4 and Q have a meaning as defined herein in the specification. The compounds of formula (I) are allost...	12/21/2010

«First «Previous1 2 3 4 5 6 7 8 9 10 11 Next»Last»

PatentStorm

Bizarre Patents

PatentStorm News

Sackey, Ebenezer

Patents as Assistant Examiner